Diphenyl Phosphite
|
亚磷酸二苯酯
|
4712-55-4
|
3-Fluorobenzotrichloride
|
3-氟三氯甲苯
|
401-77-4
|
Methhimidazole impurity G
|
甲硫咪唑杂质G
|
|
GLT-2
|
P-[2-[[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氢-3-呋喃基]氧基-6-喹唑啉基]氨基]-2-氧代乙基]膦酸二乙酯
|
618061-76-0
|
Oseltamivir impurity
|
奥司他韦杂质
|
903907-74-4
|
Benidipine impurities
|
贝尼地平杂质
|
43107-08-0
|
ZOPICLONE N-OXIDE
|
佐匹克隆氮氧化物杂质
|
43200-96-0
|
BB-1
|
苯巴那酯中间体
|
1259059-71-6
|
TL102
|
1-(2-氯苯基)-2-溴乙醇
|
72702-57-9
|
Resorcinol oxidizing impurities
|
间苯三酚氧化杂质
|
|
Trazodone Impurity M
|
曲唑酮杂质M
|
|
Mirabegron impurity E nitrosamines
|
米拉贝隆杂质E亚硝胺
|
|
1-Furan-2-yl-ethanol
|
1-(2-呋喃基)乙醇
|
4208-64-4
|
2-Amino-5,6-dichloro-3,4-dihydroquinazoline(INF01)
|
5,6-二氯-1,4-二氢喹唑啉-2-胺(INF01)
|
444904-63-6
|
Nateglinide Impurity G
|
那格列奈杂质G对照品
|
187728-85-4
|
Tecovirimat
|
替韦立马
|
869572-92-9
|
Pembrolizumab
|
帕博利珠单抗
|
1374853-91-4
|
Flunarizine EP Impurity B
|
氟桂利嗪EP杂质B
|
27064-96-6
|
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(2-methoxyacetyl)amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
|
(2S,5R,6R)-6-(2-甲氧基乙酰氨基)-3,3-二甲基-7-氧代-4-硫代-1-氮杂双环[3.2.0]庚烷-2-羧酸
|
646536-87-0
|
Isopropyl benzenesulfonate
|
苯磺酸异丙酯
|
6214-18-2
|
Voltioxetine impurity J
|
伏硫西汀杂质J
|
2925447-38-5
|
N-nitrososulfopride impurity
|
N-亚硝基氨磺必利杂质
|
|
Flunarizine EP Impurity A
|
氟桂利嗪EP杂质A
|
27469-60-9
|
Risperidone-d4
|
利培酮-d4
|
1020719-76-9
|
Hydrocortisone sodium phosphate
|
氢化可的松磷酸钠
|
6000-74-4
|
Fmoc-Gln(Trt)-Gln(Trt)-OH
|
乙酰半胱氨酸杂质
|
2244048-22-2
|
GLT-I
|
(E)-4-(二甲基氨基)丁-2-烯酸
|
149586-32-3
|
Aspartame-related substance A standard (5-benzyl-3,6-dioxo-2-piperazine acetic acid)
|
阿斯巴甜相关物质A标准品(5-苄基-3,6-二氧-2-哌嗪乙酸)
|
55102-13-1
|
N-nitrosogatifoxacin
|
N-亚硝基加替沙星
|
|
Vitamin K1 impurity A049-III.a
|
维生素K1杂质A049-Ⅲa
|
|
Nimodipine Impurity V
|
尼莫地平杂质V
|
|
Methyltrienolone
|
美曲勃龙
|
965-93-5
|
Flunarizine hydrochloride IIa-2
|
盐酸氟桂利嗪IIa-2
|
4510-34-3
|
γ-L-Glutamyl-L-glutamic acid
|
杂质B:γ-谷氨酰基-L-谷氨酸
|
1116-22-9
|
Flunarizine hydrochloride F
|
盐酸氟桂利嗪杂质F
|
88172-16-1
|
Furan-2-carbonyl cyanide
|
2-呋喃基甲酰腈
|
6047-91-2
|
SM-1hd
|
(S)-2-(氧杂环丁烷-2-基)乙-1-醇
|
95404-59-4
|
2-[3-(bis-[1,2,4]-triazol-1-yl-methyl)-5-(cyano-dimethyl)-phenyl]-2-methyl-propionitrile
|
2-[3-(双-[1,2,4]-三唑-1-基-甲基)-5-(氰基-二甲基)-苯基]-2-甲基-丙腈
|
1186102-55-5
|
Diclofenac epolamine
|
双氯芬酸依泊胺
|
119623-66-4
|
nitro-p-phenylenediamine N1-monoacetate
|
硝基-对苯二胺 N1-单乙酸酯
|
7418-43-1
|
BML/M3 impurityB
|
BML/M3杂质B
|
|
Mirabegron impurity F nitrosamines
|
米拉贝隆杂质F亚硝胺
|
|
Relebactam impurity 65
|
瑞来巴坦杂质65
|
|
Potassium o-pentylhydroxybenzoate
|
邻戊羟基苯甲酸钾
|
578-36-9
|
TL302
|
2-氯苯基环氧乙烷
|
62717-50-4
|
Donafenib
|
多纳非尼
|
1130115-44-4
|
Cefazolin impurity 7/Cefazolin EP Impurity J/2-((2-(1H-tetrazol-1-yl)acetamido)(carboxy)methyl)-5-methylene-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
|
头孢唑林杂质0(EP杂质J)
|
1675245-00-7
|
20506-3-IM3
|
20506-3-IM3
|
|
Paliperidone Impurity D
|
帕利哌酮杂质D
|
1189516-65-1
|
Adipamide
|
己二酰胺
|
628-94-4
|
Cefaclor Impurity 39
|
头孢克洛杂质39
|
|
FSM/Impurity M
|
FSM/杂质M
|
|
YQCJ-4
|
YQCJ-4
|
|
Indobufen Impurity VII
|
吲哚布芬杂质VII
|
|
(E)-(3-Chloroprop-1-en-1-yl)benzene
|
(E)-(3-氯丙-1-烯-1-基)苯
|
21087-29-6
|
Hydrochlorothiazide Impurity 19
|
5,6-二氯-3-氨基-1,3-二磺酸基氯
|
5250-71-5
|
2,5-Dihydro-2,5-dimethoxyfuran
|
2,5-二甲氧基二氢呋喃
|
332-77-4
|
Cyclopentylmethanamine
|
甲氨基环戊烷
|
6053-81-2
|
pentadecanoic acid
|
十五烷酸
|
1002-84-2
|
Methyl nonanoate
|
壬酸甲酯
|
1731-84-6
|
7-Nitro-1,3-benzodioxole-5-carboxaldehyde
|
7-硝基苯并[d][1,3]二噁唑-5-甲醛
|
209120-51-4
|
DL-alpha-Amino-epsilon-caprolactam hydrochloride
|
赖氨酸内酯
|
29426-64-0
|
Benzamide, 4-amino-5-(ethylsulfonyl)-2-methoxy-
|
4-氨基-5-(乙基磺酰基)-2-甲氧基苯甲酰胺
|
1340546-20-4
|
((R,R)-2-amino-1,2-diphenylethyl)[(4-tolyl)sulfonyl]amido](p-cymene)ruthenium(ii)chloride
|
(R,R)-N-(对甲苯磺酰)-1,2-二苯乙烷二胺(对异丙基苯)氯化钌
|
192139-92-7
|
Nitroso-A
|
亚硝基-A
|
|
20506-2-IM1 (Piroxicam Impurity 6)
|
20506-2-IM1(吡罗昔康杂质6)
|
|
Urapidil Impurity(w-2-C)
|
乌拉地尔杂质(w-2-C)
|
84145-43-7
|
1,2-Diaminocyclohexane
|
1,2-二氨基环己烷
|
694-83-7
|
Omeprazole Impurity SM2-8
|
奥美拉唑杂质SM2-8
|
143016-68-6
|
2-mercapto-5-nitrobenzimidazole
|
2-巯基-5-硝基苯并咪唑
|
6325-91-3
|
Omeprazole Impurity D
|
奥美拉唑杂质D
|
88546-55-8
|
myramstin
|
米拉米斯停
|
15809-19-5
|
Urapidil Impurity(w-2-B)
|
乌拉地尔杂质(w-2-B)
|
16015-71-7
|
6-Chloro-5-nitro-2-(propylthio)pyrimidin-4-ol (MDIP-6)
|
6-氯-5-硝基-2-(丙硫基)嘧啶-4-醇(MDIP-6)
|
|
6-AMINO CAPRONITRILE
|
6-氨基己腈
|
2432-74-8
|
20506-2
|
吡罗昔康杂质 H
|
24683-21-4
|
poricoicacidB
|
茯苓新酸B
|
137551-39-4
|
Prednisolone ImpurityC
|
泼尼松龙杂质C
|
61549-70-0
|
N-Acetyl-Phytosphingosine
|
N-乙酰基植物鞘氨醇
|
21830-28-4
|
Erythromycin B standard
|
红霉素B标准品
|
527-75-3
|
Trazodone Impurity D
|
曲唑酮杂质D
|
1263358-13-9
|
Prednisolone Impurity B
|
泼尼松龙杂质B
|
37927-29-0
|
Lysine impurity K
|
赖氨匹林杂质K
|
|
7-ADCA-Dimer
|
7-ADCA二聚体
|
|
1H-Pyrrole-1-carboxylic acid, 2-cyano-2,3-dihydro-, 1,1-dimethylethyl ester, (2S)-
|
普卢格列汀HA1117-杂质53
|
1448789-92-1
|
Gadoxetate Disodium Impurity D
|
钆塞酸二钠杂质D
|
221640-03-5
|
Urapidil Impurity(w-4-1)
|
乌拉地尔杂质(w-4-1)
|
688753-86-8
|
Nimodipine Impurity IV
|
尼莫地平杂质IV
|
|
Gadoxetate disodium Impurity 5
|
钆塞酸二钠杂质5
|
|
NA
|
20506-2-IM2(吡罗昔康杂质5)
|
|
Vonolagenic impurities LZ100528
|
伏诺拉生杂质LZ100528
|
|
20506-1
|
2-(1,1-二氧-3-氧代苯并[D]异噻唑-2(3H)-基)乙酸乙酯
|
24683-20-3
|
N-nitroso-desmethyl-escitalopram
|
N-亚硝基-去甲基艾司西酞普兰
|
|
NA
|
(2S,5R,6R)-6-(2-氯乙酰氨基)-3,3-二甲基-7-氧代-4-硫代-1-氮杂双环[3.2.0]庚烷-2-羧酸
|
68641-64-5
|
N-Nitroso Cimetidine
|
N-亚硝基西咪替丁
|
73785-40-7
|
Methhimidazole impurity E
|
甲巯咪唑杂质E
|
|
BML/M1 impurity B
|
BML/M1杂质B
|
|
Cefotiam impurity L
|
头孢替安杂质L
|
|
Octreotide Impurity H
|
奥曲肽杂质H
|
|
(S)-2-(4-hydroxybenzylamino)propanamide
|
(S)-2-(4-羟基苄胺基)丙酰胺
|
1218238-48-2
|